STRATEC Biomedical AG (SBSG.DE)
SBSG.DE on Xetra
60.80EUR
17 Aug 2018
60.80EUR
17 Aug 2018
Change (% chg)
€-3.90 (-6.03%)
€-3.90 (-6.03%)
Prev Close
€64.70
€64.70
Open
€64.20
€64.20
Day's High
€64.40
€64.40
Day's Low
€60.30
€60.30
Volume
25,054
25,054
Avg. Vol
7,923
7,923
52-wk High
€80.30
€80.30
52-wk Low
€48.97
€48.97
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Fred Brueckner |
74 | 2000 | Chairman of the Supervisory Board |
Marcus Wolfinger |
50 | 2010 | Chairman of the Management Board, Chief Executive Officer |
Rainer Baule |
Vice Chairman of the Supervisory Board | ||
Robert Siegle |
50 | 2011 | Director of Finance and Human Resources, Member of the Board of Management |
Claus Vielsack |
50 | 2014 | Member of the Management Board, Director of Product Development |
Stefanie Remmele |
39 | 2014 | Member of the Supervisory Board |
Jan Keppeler |
2017 | Head of Investor Relations & Corporate Communications |
Biographies
| Name | Description |
|---|---|
Fred Brueckner |
Mr. Fred K. Brueckner has been Chairman of the Supervisory Board of STRATEC Biomedical AG since March 2000. Before that, he served as Member of the Supervisory Board at the Company from May 1998. Mr. Brueckner is a Chemical Engineer and Independent Management Consultant. |
Marcus Wolfinger |
Mr. Marcus Wolfinger has been Chairman of the Management Board and Chief Executive Officer at STRATEC Biomedical AG since April 1, 2010. Prior to that he served as Chief Financial Officer and Member of the Management Board of the Company from July 1, 1999. He joined STRATEC Biomedical Systems AG on March 1, 1998 as Commercial Manager. Mr. Wolfinger holds a degree in Business Administration. |
Rainer Baule |
Mr. Rainer Baule serves as Vice Chairman of the Supervisory Board at STRATEC Biomedical AG. He joined the Company's Supervisory Board on June 14, 2017. |
Robert Siegle |
Dr. Robert Siegle has been Director of Finance and Human Resources and Member of the Board of Management at STRATEC Biomedical AG since February 1, 2011. Prior to that, he served as Deputy Chairman of the Supervisory Board at the Company from May 1998 until December 31, 2010. Dr. Siegle is a Self-Employed Lawyer. He has been Member of the Management of STRATEC Molecular GmbH since December 2012 and Member of the Administrative Board of STRATEC Biomedical Switzerland AG since March 2014. Dr. Siegle was Member of the Board of STRATEC Biomedical UK, Ltd. until July 2014. |
Claus Vielsack |
Dr. Claus Vielsack has been Member of the Management Board and Director of Product Development at STRATEC Biomedical AG since February 15, 2014. He joined the Company on September 1, 1998 and has held various senior product development positions. He holds a degree in Chemistry. |
Stefanie Remmele |
Prof. Dr. Stefanie Remmele has been Member of the Supervisory Board of STRATEC Biomedical AG since June 18, 2014. She graduated in Electrical Engineering, She has been Professor for medical engineering at the Hochschule Landshut, Germany – University of Applied Sciences. |
Jan Keppeler |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Fred Brueckner |
54,000 |
Marcus Wolfinger |
874,000 |
Rainer Baule |
-- |
Robert Siegle |
612,000 |
Claus Vielsack |
566,000 |
Stefanie Remmele |
29,000 |
Jan Keppeler |
-- |
As Of
31 Dec 2016
Options Compensation
| Name | Options | Value |
|---|---|---|
Fred Brueckner |
0 | 0 |
Marcus Wolfinger |
0 | 0 |
Rainer Baule |
0 | 0 |
Robert Siegle |
0 | 0 |
Claus Vielsack |
0 | 0 |
Stefanie Remmele |
0 | 0 |
Jan Keppeler |
0 | 0 |